CervoMed Inc. (CRVO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.40
• Market Cap: $40.62M
• EPS: $-2.90
• 52-Week High: $16.94
• 52-Week Low: $1.92

Market Sentiment

CervoMed Inc. currently has a Neutral sentiment score of -0.13.

About CervoMed Inc.

CervoMed Inc. is a clinical-stage biotechnology company based in Boston, Massachusetts, dedicated to developing innovative therapeutic solutions for neurodegenerative diseases, including Alzheimer's and Parkinson's. By harnessing advanced research methodologies and a promising drug pipeline, CervoMed seeks to fulfill significant unmet medical needs in these challenging fields. With a strategic focus on drug development, the company is well-positioned to become a key player in the transformati...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for CervoMed Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRVO pay dividends?

CervoMed Inc. (CRVO) does not currently pay a regular dividend.

What is CRVO's market cap?

CervoMed Inc. (CRVO) has a market capitalization of $40.62M with a current stock price of $4.40.